MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

NeoGenomics Inc

Chiusa

6.24 -6.73

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

6.21

Massimo

6.71

Metriche Chiave

By Trading Economics

Entrata

-11M

-26M

Vendite

-4M

168M

Margine di Profitto

-15.427

Dipendenti

2,200

EBITDA

-10M

-6.3M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+59.97% upside

Dividendi

By Dow Jones

Utili prossimi

29 lug 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-359M

924M

Apertura precedente

12.97

Chiusura precedente

6.24

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bearish Evidence

NeoGenomics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

18 lug 2025, 14:33 UTC

I principali Market Mover

MEI Pharma Stock Surges on $100 Million Private Placement, Litecoin Treasury Strategy

17 lug 2025, 21:14 UTC

Acquisizioni, Fusioni, Takeovers

Basel Medical Group Puts $1 Billion Bitcoin Purchase on Hold

17 lug 2025, 18:49 UTC

Acquisizioni, Fusioni, Takeovers

Bitcoin Standard Treasury to Go Public Via SPAC Deal

14 lug 2025, 17:06 UTC

I principali Market Mover

Crypto Assets Rally Ahead of Possible U.S. Legislation

18 lug 2025, 14:31 UTC

Discorsi di Mercato

U.S. Regulation is Driving Crypto Demand -- Market Talk

18 lug 2025, 14:18 UTC

I principali Market Mover

MEI Pharma Stock Surges on $100M Private Placement, Litecoin Treasury Strategy

18 lug 2025, 07:06 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

18 lug 2025, 07:06 UTC

Discorsi di Mercato

Bitcoin Rises on Optimism Over U.S. Regulation -- Market Talk

17 lug 2025, 21:45 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

17 lug 2025, 21:45 UTC

Discorsi di Mercato

Crypto Bills Welcomed by Venture Capital, Trade Group Says -- Market Talk

17 lug 2025, 20:59 UTC

Acquisizioni, Fusioni, Takeovers

Basel Medical Group Puts $1B Bitcoin Purchase on Hold

17 lug 2025, 14:37 UTC

Discorsi di Mercato

Ethereum Outperforms as Bitcoin Stays Stuck Below $120,000 -- Market Talk

17 lug 2025, 13:06 UTC

Acquisizioni, Fusioni, Takeovers

Cantor Equity Partners I, Upon Closing, Combined Company Expected to Trade Under Ticker Symbol BSTR >CEPO

17 lug 2025, 13:06 UTC

Acquisizioni, Fusioni, Takeovers

Bitcoin Standard Treasury to Go Public Through Business Combination With Cantor Equity Partners I

17 lug 2025, 09:19 UTC

Discorsi di Mercato

Bitcoin Falls, Stays at High Levels Amid Focus on U.S. Legislation -- Market Talk

17 lug 2025, 09:19 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

16 lug 2025, 13:41 UTC

Acquisizioni, Fusioni, Takeovers

This Crypto Stock Is Soaring. Peter Thiel Just Made a Big Bet. -- Barrons.com

16 lug 2025, 11:16 UTC

Acquisizioni, Fusioni, Takeovers

This Crypto Stock Soared 30%. Peter Thiel Just Made a Big Bet. -- Barrons.com

16 lug 2025, 09:05 UTC

Discorsi di Mercato

Bitcoin Turns Higher Again Ahead of Possible U.S. Legislation -- Market Talk

15 lug 2025, 15:15 UTC

Discorsi di Mercato

Sovereign Adoption of Bitcoin is Rising -- Market Talk

15 lug 2025, 14:40 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

15 lug 2025, 14:40 UTC

Discorsi di Mercato

Stablecoins Aren't a Long-Term Store of Value -- Market Talk

15 lug 2025, 14:05 UTC

Discorsi di Mercato

Investors More Sensitive to Risk of Crypto Collapse -- Market Talk

15 lug 2025, 13:20 UTC

Discorsi di Mercato

Bitcoin's Recent Rally Could Extend Further -- Market Talk

15 lug 2025, 13:20 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

15 lug 2025, 12:42 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

15 lug 2025, 12:42 UTC

Discorsi di Mercato

Widespread Bitcoin Adoption Is Still Some Way Off -- Market Talk

15 lug 2025, 08:22 UTC

Discorsi di Mercato

Bitcoin Hit by Profit-Taking After Surge to Record Highs -- Market Talk

14 lug 2025, 15:54 UTC

Discorsi di Mercato

Market Talk Roundup: Latest on U.S. Politics

14 lug 2025, 15:54 UTC

Discorsi di Mercato

'Crypto Week' Legislation Would Overhaul U.S. Crypto Policy -- Market Talk

Confronto tra pari

Modifica del prezzo

NeoGenomics Inc Previsione

Obiettivo di Prezzo

By TipRanks

59.97% in crescita

Previsioni per 12 mesi

Media 10.75 USD  59.97%

Alto 12 USD

Basso 8.5 USD

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per NeoGenomics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

10 ratings

6

Acquista

4

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

7.7 / 10.27Supporto e resistenza

A breve termine

Very Strong Bearish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.